`Wide-spectrum Ca 2+ channel antagonists': lipophilicity, inhibition, and recovery of secretion in chromaffin cells

By Lara B.   Ganda L.   Torres A.   Olivares R.   Martnez-Sierra R.   Garca A.G.   Lopez M.G.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 109-119

Elsevier

Access to resources Recommend Favorite

Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca 2+

By Novalbos J.   Abad-Santos F.   Zapater P.   Cano-Abad M.F.   Moradiellos J.   Sanchez-Garca P.   Garca A.G.  

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 309-317

Elsevier

Access to resources Recommend Favorite

Enhancement of tamoxifen-induced E-cadherin function by Ca 2+ channel antagonists in human breast cancer MCF7/6 cells

By Charlier C.   Bruyneel E.   Lechanteur C.   Bracke M.   Mareel M.   Castronovo V.  

European Journal of Pharmacology, Vol. 317, Iss. 2, 1996-12 ,pp. : 413-416

Elsevier

Access to resources Recommend Favorite

Ca 2+ channel antagonists and neuroprotection from cerebral ischemia

By Kobayashi T.   Mori Y.  

European Journal of Pharmacology, Vol. 363, Iss. 1, 1998-12 ,pp. : 1-15

Elsevier

Access to resources Recommend Favorite

Effects of A23187 and CaCl 2 on tri-n-butyltin-induced cell death in rat thymocytes

By Oyama Y.   Arata T.   Chikahisa L.   Umebayashi C.   Tabaru K.   Sakai K.   Hayashi H.  

Environmental Toxicology and Pharmacology, Vol. 13, Iss. 1, 2003-01 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite